Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism

NCT03927508 is registered in ClinicalTrials.gov with Thrombolex, Inc. as lead sponsor.

NCT NCT03927508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03927508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism
Lead sponsor
Thrombolex, Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 14, 2019
Completion date
January 23, 2020
Enrollment
9 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism